Drugs / T Regulatory Cell Infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02091232 | May 2014 → Mar 2016 | kidney failure | Massachusetts General Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | T Regulatory Cell Infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02091232 ↗ |
| Modality | Cell therapy | “Regulatory cell therapy is achievable and safe in living-donor kidney transplant recipients” PMID 32446407 ↗ May 2020 |